Medical Oncology and Hematology 2012: Clinical and Scientific Approaches that Enhance Patient Outcomes
Upcoming SlideShare
Loading in...5
×
 

Medical Oncology and Hematology 2012: Clinical and Scientific Approaches that Enhance Patient Outcomes

on

  • 935 views

 

Statistics

Views

Total Views
935
Views on SlideShare
895
Embed Views
40

Actions

Likes
0
Downloads
3
Comments
0

1 Embed 40

http://www.mdconferencefinder.com 40

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Medical Oncology and Hematology 2012: Clinical and Scientific Approaches that Enhance Patient Outcomes Medical Oncology and Hematology 2012: Clinical and Scientific Approaches that Enhance Patient Outcomes Document Transcript

  • Medical Oncology and Hematology 2012: Clinical and Scientific Approaches that Enhance Patient Outcomes October 18–20, 2012 The University of TexasMD Anderson Cancer Center R. Lee Clark ClinicFloor 11, Hickey Auditorium 1515 Holcombe Boulevard Houston, Texas
  • Goal The goal of this program will be to address the ongoing need for education of practicing physicians with new cancer therapy and updating treatment guidelines and focus on new advances within the last year and other groundbreaking scientific discoveries. At the conclusion of the conference, physicians and other healthcare providers will have a new awareness and knowledge in optimal use of new therapies for cancer. Educational Objectives After attending the conference, participants should be able to • Incorporate new knowledge for each cancer diagnosis to articulate optimal treatments guided by prognostic factors and treatment options (Knowledge, Competence, Performance, and Patient Outcomes). • Utilize available clinical trials for promising new treatments and appropriately selectMedical Oncology and Hematology 2012: candidates for referral (Knowledge, Competence, Performance, and Patient Outcomes). • Apply principles of personalized cancer treatment for each diagnosis (Knowledge,Clinical and Scientific Approaches that Enhance Patient Outcomes Competence, Performance, and Patient Outcomes). • Implement new knowledge of cancer genetics to improve treatment of cancer October 18–20, 2012 patients (Knowledge, Competence, Performance, and Patient Outcomes). The University of Texas MD Anderson Cancer Center R. Lee Clark Clinic, Floor 11 – Hickey Auditorium, 1515 Holcombe Boulevard, Houston, Texas Target Audience This conference will be beneficial to primary care physicians, medical oncologists and hematologists, trainees, fellows, and other healthcare professionals.Program Chair Program Co-ChairsHagop M. Kantarjian, MD Raymond N. DuBois, MD, PhD Richard E. Champlin, MD Lyle D. Green, MBAOrganizing Committee Yvonne S. Bazunu Doreen Brandenberger Elnar Koseoglu Tina Nelson, CMP
  • Educational Method• Lectures/Didactic• Question and Answer Session• Conference Post-EvaluationEvaluationA course evaluation form will provide participants with theopportunity to comment on the value of the program content totheir practice decisions, performance improvement activities, orpossible impact on patient health status. Participants will alsohave the opportunity to comment on any perceived commercialbias in the presentations as well as to identify futureeducational topics.Accreditation/Credit DesignationThe University of Texas MD Anderson Cancer Center is accredited Programby the Accreditation Council for Continuing Medical Education toprovide continuing medical education for physicians.The University of Texas MD Anderson Cancer Center designatesthis live activity for a maximum of 14.50 AMA PRA Category 1CreditsTM. Physicians should claim only the credit commensuratewith the extent of their participation in the activity. Thursday, October 18, 2012CME Certificates and AttendanceVerification Certificates 2:00 pm RegistrationCertificates awarding AMA PRA Category 1 CreditTM or certificatesdocumenting attendance will be distributed to participants when 3:00 Welcome and Opening Remarksan individual departs the conference. To obtain a CME certificate, Raymond N. DuBois, MD, PhDphysicians must submit a completed evaluation questionnaire anda CME Verification Form. PLENARY SESSIONSUpon request, a record of attendance (certificate) will be providedon-site to other health care professionals for requesting credits in 3:15 Overview of Clinical Trialsaccordance with state nursing boards, specialty societies, or Aman U. Buzdar, MDother professional associations. 4:00 Translating the Cancer Genome Lynda Chin, MDFollow @Physrelations on Twitter 4:45 Closing Remarks/Preview of Day TwoGet real-time conference updates and join the Peter C. Hu, PhDdiscussion with The #MOHC2012 hashtag.Join us for a joint reception/tweetup at 5:30 p.m.on Friday, October 19, 2012.
  • What’s New in Solid Tumors? THORACIC/HEAD & NECK SESSION 8:40 The Importance of Molecular Diagnostics and Therapy in Lung Cancer George R. Blumenschein, Jr., MD 9:00 Latest Treatments of Head and Neck Cancer Merrill S. Kies, MD 9:20 Ask the Experts 9:35 Break GENITOURINARY SESSION 9:45 Targeted Therapies in Renal Cell Cancer Nizar M. Tannir, MD 10:05 Prostate Cancer Overview Christopher J. Logothetis, MD Friday, October 19, 2012 10:25 Testicular Cancer/Germ Cell Tumors Lance C. Pagliaro, MD7:00 am Registration and Continental Breakfast 10:45 Ask the Experts8:00 Welcome and Opening Remarks BRAIN SESSION Ronald A. DePinho, MD 11:00 State-of-the-Art Approach to Brain Tumor Therapy W.K. Alfred Yung, MD8:10 KEYNOTE SPEAKER Healthcare Reform - Impact on Cancer Care 11:20 Ask the Expert Thomas W. Burke, MD
  • MELANOMA SESSION 2:25 The Immunotherapy of Melanoma Patrick Hwu, MD 2:40 Targeted Therapy of Melanoma Michael A. Davies, MD, PhD 2:55 Ask the Experts SARCOMA SESSION 3:10 Overview of Sarcoma Therapy Vinod Ravi, MD 3:30 Ask the Expert 3:45 Break BREAST SESSION PERSONALIZED THERAPY SESSION 4:00 Treatment of Early Stage Breast Cancer11:35 Delivering Personalized Therapy in Solid Tumors Vicente Valero, MD Apostolia M. Tsimberidou, MD, PhD 4:20 Treatment of Late Stage Breast Cancer Ricardo Hugo Alvarez, MD11:55 Ask the Expert 4:40 Novel Strategies for Inflammatory Breast Cancer Naoto T. Ueno, MD, PhD GYNECOLOGICAL SESSION 5:00 Ask the Experts12:00 pm Lunch (provided) Treatment of Gynecological Cancers 5:15 Adjourn Karen H. Lu, MD 5:30 Bienvenido a la Recepción - Please Join Us (Come visit with Colleagues)12:35 Ask the Expert GASTROINTESTINAL SESSION1:00 Esophageal and Gastric Cancer Jaffer A. Ajani, MD1:30 New Developments in Colorectal Cancer Treatment Arvind Dasari, MBBS1:50 Pancreas and NET James C. Yao, MD2:10 Ask the Experts
  • MD ANDERSON FACULTY Saturday, October 20, 2012 Ronald A. DePinho, MD Professor, President Hagop M. Kantarjian, MD Professor and Chair Thomas W. Burke, MD Leukemia7:00 am Registration and Continental Breakfast Professor, Executive Vice President Merrill S. Kies, MD and Physician-In-Chief Professor8:00 Welcome and Opening Remarks Raymond N. DuBois, MD, PhD Thoracic/Head and Neck Medical Oncology Elizabeth Shpall, MD Professor Provost and Executive Vice President Christopher J. Logothetis, MD Jaffer A. Ajani, MD Professor and Chair Professor Genitourinary Medical Oncology Gastrointestinal Medical Oncology Karen H. Lu, MD What’s New in Hematology? Ricardo Hugo Alvarez, MD Professor Gynecologic Oncology Assistant Professor Breast Medical Oncology Lance C. Pagliaro, MD HEMATOLOGY SESSION Associate Professor George R. Blumenschein, Jr., MD8:10 State-of-the-Art Treatment of Acute Lymphoblastic Associate Professor Genitourinary Medical Oncology Leukemia and Acute Myelogenous Leukemia Thoracic/Head & Neck Vinod Ravi, MD Medical Oncology Assistant Professor Stefan H. Faderl, MD Sarcoma Medical Oncology Aman U. Buzdar, MD8:30 Treatment of Chronic Myelogenous Leukemia Professor, Breast Medical Oncology Jatin Shah, MD Assistant Professor Jorge E. Cortes, MD Richard E. Champlin, MD Lymphoma/Myeloma Professor and Chair8:50 Treatment of Chronic Lymphocytic Leukemia Stem Cell Transplantation Elizabeth Shpall, MD and Cellular Therapy Professor William G. Wierda, MD, PhD Stem Cell Transplantation Lynda Chin, MD9:10 Treatment of Myelodysplastic Syndrome Professor and Chair Nizar M. Tannir, MD Genomic Medicine Associate Professor Guillermo Garcia-Manero, MD Genitourinary Medical Oncology Jorge E. Cortes, MD9:30 Ask the Experts Professor, Leukemia Apostolia M. Tsimberidou, MD, PhD Arvind Dasari, MBBS Associate Professor9:45 Break Assistant Professor Investigational Cancer Therapeutics Gastrointestinal Medical Oncology Naoto T. Ueno, MD, PhD10:00 Aggressive Lymphomas Michael A. Davies, MD, PhD Professor Luis E. Fayad, MD Assistant Professor Breast Medical Oncology Melanoma Medical Oncology Vicente Valero, MD10:20 Indolent Lymphomas Stefan H. Faderl, MD Professor Fredrick B. Hagemeister, MD Professor, Leukemia Breast Medical Oncology Luis E. Fayad, MD William G. Wierda, MD, PhD10:40 Hodgkin’s Disease Associate Professor Associate Professor Anas Younes, MD Lymphoma/Myeloma Leukemia Guillermo Garcia-Manero, MD James C. Yao, MD11:00 Myeloma Professor, Leukemia Associate Professor Jatin Shah, MD Gastrointestinal Medical Oncology Fredrick B. Hagemeister, MD Professor Anas Younes, MD11:20 Ask the Experts Lymphoma/Myeloma Professor Lymphoma/Myeloma11:35 Novel Strategies in Stem Cell Transplantation Peter C. Hu, PhD Associate Professor W.K. Alfred Yung, MD Elizabeth Shpall, MD School of Health Professions Professor and Chair Neuro-Oncology12:00 pm Closing Remarks and Adjourn Patrick Hwu, MD Professor and Chair Melanoma Medical Oncology
  • Registration Information Special AssistanceOn-site registration will open at 2:00 p.m. on Thursday, October 18, 2012. The opening Contact the Department of CME/Conference Management at 713-792-2223 or toll free at 866-849-5866 if you have any special dietary or ADA accommodation needs.session of the conference will begin at 3:00 p.m. on Thursday, October 18, 2012 and theconference will adjourn on Saturday, October 20, 2012. Accommodations • A block of rooms has been reserved for conference attendees at the Houston MarriottAdvance registration is encouraged as space and materials are limited. Please see at the Texas Medical Center, located at 6580 Fannin Street, Houston, Texas 77030registration form for applicable fees. • Early hotel reservation is suggested. • The hotel phone number is 1-800-228-9290.The deadline for advance registration is October 8, 2012. • When you make reservations be sure to mention the Medical Oncology and Hematology 2012: “Clinical and Scientific Approaches that Enhance PatientThere are three ways to register: Outcomes” Conference to be assured of receiving the special meeting rate of• Mail to: CME/Conference Management – Unit 1381, The University of Texas $122.00 single or double occupancy. Please add 17% (Texas) state and local taxes. MD Anderson Cancer Center, P.O. Box 301439, Houston, TX 77230-1439 • Reservations and deposits received after October 8, 2012 will be confirmed if space• Fax to: 713-794-1724 is available and at current hotel published guest room rates.• On-line at www.mdanderson.org/conferences Air TravelWe accept the following forms of payment: MD Anderson has a program with United Airlines for discounted air travel. For discounts, call your travel professional or United’s MeetingWorks toll free at 800-468-7022. Outside• Check (payable through U.S. banks only) of the United States, please call your local United Airlines Reservation Office. Mention Z• Money Order Code: ZM6M and Agreement Code: 488954.• Credit Cards (MasterCard, VISA, and American Express)• Cash (on-site registration only) Ground Transportation (prices are subject to change and variable depending on location of conference)A receipt and confirmation letter will be sent to you within ten working days of receipt of • Houston is served by two airports, George Bush Intercontinental (IAH) and William P.your fee. The full conference registration fee includes the tuition, syllabus, continental Hobby (HOU).breakfasts, breaks, lunch, and welcome reception. • Taxicabs are available at an estimated cost of $50-$60 to or from William P. Hobby Airport or George Bush Intercontinental Airport. • SuperShuttle operates a shuttle bus between George Bush Intercontinental Airport and the Houston Marriott at the Texas Medical Center for $27 one-way and $54 round-Refund/Cancellation Policy: trip. For more information, call 713-523-8888 or toll free at 800-258-3826, or online atThe registration fee, minus a $50 administrative handling fee, is refundable www.supershuttle.com.if a written request is received on or before October 8, 2012. No refunds will be granted after • SuperShuttle operates a shuttle bus between William P. Hobby Airport and thethat date. The request for a registration refund must include the tax identification number of Houston Marriott at the Texas Medical Center for $24 one-way and $48 round-trip.the company or institution if registration was paid by a company or institution check. For more information, call 713-523-8888 or toll-free at 800-258-3826, or online at www.supershuttle.com.The Department of CME/Conference Management reserves the right to cancel activities priorto the scheduled date, if low enrollment or other circumstances make it necessary. Each Please let us know what specific topics, issues or questions you wish to see addressed or emphasized in thisregistrant will be notified by mail, e-mail, or the contact numbers as given on the registration activity. Fax or e-mail CME/Conference Management. All responses will be forwarded to the Program Chairform. In case of activity cancellation, liability of the Department of CME/Conference for consideration.Management is limited to the registration fee. CME/Conference Management will refund the The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who isfull registration fee. The Department of CME/Conference Management reserves the right to in a position to control the content of an educational activity must disclose all relevant financial relationshipslimit the number of participants in a program and is not responsible for any expenses incurred with any commercial interest that could potentially affect the information presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) ofby an individual whose registration is not confirmed and for whom space is not available. pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.For additional information, contact CME/Conference Management at 713-792-2223 or toll Agendas are subject to change because we are always striving to improve the quality of your educationalfree at 866-849-5866. experience. MD Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, schedule conflicts, and so forth. Photographing, audio taping and videotaping are prohibited.
  • and uuu Conference 5:30 – 7:00 p.m. Cordially invite you to attend a receptionHosted by the Office of Physician Relations Dr. Ronald A. DePinho Dr. Hagop M. Kantarjian Friday, October 19, 2012 This reception is being held in conjunction Conference Chair, Professor and Chair, Leukemia 1515 Holcombe Blvd., Houston, Texas 77030 with theMedical Oncology and Hematology 2012: Hickey Auditorium Foyer Main Building, Floor 11 The University of Texas MD Anderson Cancer Center Clinical and Scientific Approaches that Enhance Patient Outcomes Please Join Us President, The University of Texas MD Anderson Cancer Center CONFERENCE REGISTRATION - 0591 THIS IS NOT A SELF-MAILER-Address to: Medical Oncology and Hematology 2012 Medical Oncology and Hematology 2012: Department of CME/Conference Management – Unit 1381 Clinical and Scientific Approaches that Enhance Patient Outcomes – October 18–20, 2012 The University of Texas MD Anderson Cancer Center PO Box 301439, Houston, TX 77230-1439 Last Name First MI Highest Degree or fax to 713-794-1724 Make check or money order payable to: Department (include box no.) Specialty The University of Texas MD Anderson Cancer Center Institution Physician oYes oNo REGISTRATION FEES Street City State/Foreign Country/Zip or Mail Code Physicians/Scientists 1 Postmarked before 10/8/12......................$175.00 Daytime Phone (with area code) Cell Phone (with area code) Fax (with area code) 1 Postmarked after 10/8/12.........................$225.00 E-mail Address Emergency Contact Phone (with area code) MD Anderson Faculty/ Alumni 1 Postmarked before 10/8/12......................$100.00 Charge the following: 1 Postmarked after 10/8/12.........................$125.00 oVISA oMasterCard oAmerican Express Credit Card Holder Name (First/Last) Credit Card Holder Billing Address & ZIP Code Fellows/Students/Residents 1 Postmarked before 10/8/12......................$ 50.00 Credit Card Number or MD Anderson Interdepartmental Transfer (IDT) No. Expiration Date MD Anderson Staff, Trainees & Allied Health Professionals Authorized Signature REQUIRED for credit card or IDT MD Anderson Employee ID No. (REQUIRED) 1 Postmarked before 10/8/12......................$ 50.00 Healthcare Professionals IDT Approver Name (First/Last) please print IDT Approver E-mail 1 Postmarked before 10/8/12......................$ 100.00 1 Postmarked after 10/8/12.........................$ 125.00
  • The University of Texas MD Anderson Cancer CenterCME/Conference Management - Unit 1381 Non-Profit Org.176700/30070591 U.S. PostagePO Box 301439 PAIDHouston, Texas 77230-1439 Houston, TX Permit No. 7052